Publication | Closed Access

The potential and limitations of DOV 216,303 as a triple reuptake inhibitor for the treatment of major depression: A microdialyis study in olfactory bulbectomized rats

Molecular PharmacologyPsychiatryNeurophysiologyMedicinePsychotropic MedicationTriple Reuptake InhibitorMajor DepressionPsychopharmacologyDepressionNeuropharmacologyDov 216,303Social SciencesNeuroscienceBiological PsychiatryDopaminePharmacologyPsychopathology